EPIZYME, INC. Lease, Cost
EPIZYME, INC. reported Lease, Cost of $2.18 million for the 3-month period ending 2022-06-30, per its 10-Q filed 2022-08-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LeaseCost · last filed 2022-08-09
- EPIZYME, INC. lease, cost for the quarter ending 2022-06-30 was $2.18M, a 4.76% increase year-over-year.
- EPIZYME, INC. lease, cost for the quarter ending 2022-03-31 was $2.18M, a 9.27% increase year-over-year.
- EPIZYME, INC. lease, cost for the quarter ending 2021-12-31 was $2.15M, a 12.74% increase year-over-year.
- EPIZYME, INC. lease, cost for the quarter ending 2021-09-30 was $2.10M, a 7.25% increase year-over-year.
- EPIZYME, INC. lease, cost for fiscal 2021 was $8.33M, a 5.19% increase from fiscal 2020.
- EPIZYME, INC. lease, cost for fiscal 2020 was $7.92M, a 55.61% increase from fiscal 2019.
- EPIZYME, INC. lease, cost for fiscal 2019 was $5.09M.
| Period end | Lease, Cost 3 month | Lease, Cost 6 month | Lease, Cost 9 month | Lease, Cost 12 month |
|---|---|---|---|---|
| 2022-06-30 | $2.18M 10-Q · filed 2022-08-09 | $4.31M 10-Q · filed 2022-08-09 | $6.51M derived: sum of 3 quarters · filed 2022-08-09 | $8.61M derived: sum of 4 quarters · filed 2022-08-09 |
| 2022-03-31 | $2.18M 10-Q · filed 2022-05-10 | $4.33M derived: sum of 2 quarters · filed 2022-05-10 | $6.43M derived: sum of 3 quarters · filed 2022-05-10 | $8.51M derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-12-31 | $2.15M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $4.25M derived: sum of 2 quarters · filed 2022-03-01 | $6.33M derived: sum of 3 quarters · filed 2022-08-09 | $8.33M 10-K · filed 2022-03-01 |
| 2021-09-30 | $2.10M 10-Q · filed 2021-11-09 | $4.18M derived: sum of 2 quarters · filed 2022-08-09 | $6.18M 10-Q · filed 2021-11-09 | $8.09M derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-06-30 | $2.08M 10-Q · filed 2022-08-09 | $4.08M 10-Q · filed 2022-08-09 | $5.98M derived: sum of 3 quarters · filed 2022-08-09 | $7.94M derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | $2.00M 10-Q · filed 2022-05-10 | $3.90M derived: sum of 2 quarters · filed 2022-05-10 | $5.86M derived: sum of 3 quarters · filed 2022-05-10 | $7.94M derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | $1.91M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $3.87M derived: sum of 2 quarters · filed 2022-03-01 | $5.95M derived: sum of 3 quarters · filed 2022-03-01 | $7.92M 10-K · filed 2022-03-01 |
| 2020-09-30 | $1.96M 10-Q · filed 2021-11-09 | $4.04M derived: sum of 2 quarters · filed 2021-11-09 | $6.01M 10-Q · filed 2021-11-09 | $7.49M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $2.08M 10-Q · filed 2021-08-09 | $4.05M 10-Q · filed 2021-08-09 | $5.53M derived: sum of 3 quarters · filed 2022-03-01 | $6.74M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $1.97M 10-Q · filed 2021-05-06 | $3.45M derived: sum of 2 quarters · filed 2022-03-01 | $4.66M derived: sum of 3 quarters · filed 2022-03-01 | $5.85M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | $1.48M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $2.68M derived: sum of 2 quarters · filed 2022-03-01 | $3.88M derived: sum of 3 quarters · filed 2022-03-01 | $5.09M 10-K · filed 2022-03-01 |
| 2019-09-30 | $1.21M 10-Q · filed 2020-11-06 | $2.40M derived: sum of 2 quarters · filed 2020-11-06 | $3.61M 10-Q · filed 2020-11-06 | |
| 2019-06-30 | $1.19M 10-Q · filed 2020-08-04 | $2.40M 10-Q · filed 2020-08-04 | ||
| 2019-03-31 | $1.21M 10-Q · filed 2020-05-04 |